Related Experiment Video
Updated: Jun 23, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Molecular Aspects of Cardiometabolic Diseases: From Etiopathogenesis to Potential Therapeutic Targets
Iveta Bernatova1, Monika Bartekova2
1Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Sienkiewiczova 1, 81371 Bratislava, Slovakia.
Insights
Cardiometabolic diseases (CMDs) are common, preventable illnesses like heart attack and diabetes. Understanding these conditions is crucial for public health and developing effective prevention strategies.
Area of Science:
- Cardiology
- Metabolic Disorders
- Public Health
Background:
- Cardiometabolic diseases (CMDs) represent a significant global health burden, encompassing conditions such as myocardial infarction, stroke, hypertension, obesity, and type 2 diabetes mellitus.
- These prevalent, often preventable, non-communicable illnesses share common risk factors and pathophysiological pathways, necessitating a holistic approach to management.
Discussion:
- The interconnectedness of cardiometabolic conditions highlights the importance of integrated research and clinical practice.
- Effective prevention and management strategies for CMDs require addressing lifestyle factors, genetic predispositions, and socioeconomic determinants.
Key Insights:
- CMDs include a spectrum of serious health issues like heart failure, kidney disease, and fatty liver disease.
- Early identification and intervention are critical for mitigating the long-term impact of these diseases.
Outlook:
- Future research should focus on personalized medicine and novel therapeutic targets for CMDs.
- Public health initiatives aimed at promoting healthy lifestyles are essential for reducing the incidence of cardiometabolic diseases.
Abstract:
Cardiometabolic diseases (CMDs) encompass a range of prevalent, often preventable, non-communicable illnesses, including myocardial infarction, stroke, cardiac insufficiency, arterial hypertension, obesity, type 2 diabetes mellitus, insulin resistance, chronic renal dysfunction, non-alcoholic fatty liver disease, and rare metabolic disorders [...].
Related Concept Videos
Pathophysiology of Cardiac Performance
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiovascular Drugs: Classification based on Therapeutic Indications

